Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glutathione peroxidase 3 preserves hepatocyte mitochondrial quality control to enhance macrophage pro-regenerative phenotype during liver regeneration.

Clinical and translational medicine·2026
Same author

Commentary: the oxygen effect as a possible contributing factor to the mechanism for FLASH protection of normal tissue.

International journal of radiation biology·2026
Same author

Tumor-to-endothelium mitochondrial transfer licenses endothelial cells for CD8<sup>+</sup> T cell recognition via mitochondrial neoantigen presentation.

bioRxiv : the preprint server for biology·2026
Same author

PINK1/Parkin promotes liver regeneration via Sigma-1 ubiquitination to inhibit ER-Mitochondrial calcium transfer.

Theranostics·2025
Same author

Impaired AMP-Dependent Protein Kinase-Mediated Neutrophil Extracellular Trap Clearance by Aged Macrophages in Sepsis-Induced Liver Injury.

Anesthesia and analgesia·2025
Same author

Nogo-B impairs efferocytosis in monocyte-derived macrophages and exacerbates septic liver injury.

JHEP reports : innovation in hepatology·2025

Related Experiment Video

Updated: Jun 2, 2026

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids
05:39

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

Published on: April 5, 2024

Sequentially-induced responses define tumour cell radiosensitivity.

Jerry R Williams1, Yonggang Zhang, Haoming Zhou

  • 1Radiation Research Laboratories, Department of Radiation Medicine, Loma Linda University & Medical Center, Loma Linda, CA 92354, USA. jrwilliams_france@yahoo.com

International Journal of Radiation Biology
|April 20, 2011
PubMed
Summary
This summary is machine-generated.

Cellular radiosensitivity comprises four distinct, sequential responses to radiation, independent of cell genotype. These responses, including hypersensitive and resistant phases, vary in inactivation rates based on specific genotypes, impacting treatment outcomes.

More Related Videos

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

Related Experiment Videos

Last Updated: Jun 2, 2026

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids
05:39

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

Published on: April 5, 2024

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

Area of Science:

  • Radiation biology
  • Cellular biology
  • Cancer research

Background:

  • Understanding cellular radiosensitivity is crucial for optimizing radiation therapy.
  • Existing models like the Hit-target (HT) and Linear-quadratic (LQ) models provide frameworks for radiosensitivity.
  • Genotype and dose significantly influence cellular responses to radiation.

Purpose of the Study:

  • To define dose-dependent and genotype-dependent components of radiosensitivity.
  • To resolve patterns of radiation-induced clonal inactivation into specific cellular responses.
  • To investigate the relationship between cellular responses and established radiobiological models.

Main Methods:

  • Examined radiosensitivity and genotype in 10 tumor cell lines.
  • Identified specific radiation doses triggering changes in clonogenic inactivation rates.
  • Analyzed inactivation patterns using log-linear functions and compared them to HT and LQ models.
  • Assessed cell-cycle redistribution and apoptosis as components of radiosensitivity.

Main Results:

  • Identified four sequential, genotype-independent responses: hypersensitive (H), resistant (R), induced repair (alpha*), and sensitive (omega*).
  • Specific dose ranges were associated with each response: H (0-0.10 Gy), R (0.1-0.2 Gy), alpha* (≥0.2 Gy), and omega* (≥3.0 Gy).
  • Log-linear patterns fitted H, alpha*, and omega* responses, but not the R response.

Conclusions:

  • Cellular radiosensitivity is composed of four distinct, sequentially induced responses.
  • H and R responses are linked to low-dose hyper-radiosensitivity and early apoptosis.
  • Alpha* and omega* responses align with HT and LQ models, associated with post-repair apoptosis.
  • Radiation induces these responses at consistent doses across all cells, but inactivation rates are genotype-dependent.